Novavax Testing Vaccine That Targets New COVID-19 Variant

Published on November 26, 2021

Novavax Inc said Friday it had started working on a version of its COVID-19 vaccine to target the variant detected in South Africa and would have the shot ready for testing and manufacturing in the next few weeks.

Read Full Article (External Site)